[Form 4] Synergy CHC Corp. Insider Trading Activity
Jaime Fickett, identified as Chief Financial Officer of Synergy CHC Corp. (SNYR), reported a grant of a stock option on 09/18/2025. The option covers 150,000 shares of common stock with an exercise price of $2.38 per share and an expiration date shown as 09/18/2030. The filing states the full award is held directly by the reporting person following the transaction. The option vests one-third on the first anniversary of the grant and the remaining two-thirds in equal monthly installments over the subsequent 24 months, subject to continued service. The form was signed by an attorney-in-fact on 09/22/2025.
- Time-based vesting aligns the CFO's incentives with multi-year shareholder value creation
- Disclosure filed promptly with a signature by attorney-in-fact, meeting reporting requirements
- Potential dilution of 150,000 shares if the option is exercised
- No performance-based conditions are disclosed; vesting is solely time-based
Insights
TL;DR: Routine executive equity award to CFO, standard multi-year vesting and five-year term.
The filing documents a non-derivative equity grant in the form of a stock option for 150,000 shares at a $2.38 exercise price, expiring 09/18/2030. Vesting is time-based: one-third after one year and the remainder monthly over 24 months. For investors, this is a customary retention and incentive tool rather than an immediate cash impact. The award increases potential future dilution if exercised, but the grant itself is a standard corporate governance practice for senior management.
TL;DR: Compensation action aligns CFO incentives with shareholders but creates future dilution if fully exercised.
The reported option is direct beneficial ownership and uses a multi-year vesting schedule tied to continued service, which is consistent with aligning executive performance and retention goals. The five-year contractual life to 09/18/2030 provides a window for potential alignment with long-term value creation. The filing contains clear vesting terms and shows timely disclosure by the issuer, meeting routine Section 16 reporting expectations.